Cargando…
Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton's Jelly, Bone Marrow, and Pancreatic Tissues
Background. Type 1 diabetes mellitus results from autoimmune destruction of β-cells. Insulin-producing cells (IPCs) differentiated from mesenchymal stem cells (MSCs) in human tissues decrease blood glucose levels and improve survival in diabetic rats. We compared the differential ability and the cur...
Autores principales: | Kao, Shih-Yi, Shyu, Jia-Fwu, Wang, Hwai-Shi, Lin, Chi-Hung, Su, Cheng-Hsi, Chen, Tien-Hua, Weng, Zen-Chung, Tsai, Pei-Jiun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532960/ https://www.ncbi.nlm.nih.gov/pubmed/26294917 http://dx.doi.org/10.1155/2015/306158 |
Ejemplares similares
-
Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
por: Tsai, Pei-Jiun, et al.
Publicado: (2012) -
Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
por: Chu, Kuo-An, et al.
Publicado: (2019) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
Xenografting of human umbilical mesenchymal stem cells from Wharton’s jelly ameliorates mouse spinocerebellar ataxia type 1
por: Tsai, Pei-Jiun, et al.
Publicado: (2019) -
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
por: Laroye, Caroline, et al.
Publicado: (2019)